Xijia Feng
Overview
Explore the profile of Xijia Feng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xia L, He Y, Sui Y, Feng X, Qian X, Liu Y, et al.
Viruses
. 2025 Jan;
16(12.
PMID: 39772229
Unlike other ubiquitin-like family members, UBL5 is structurally and functionally atypical, and a novel role in various biological processes and diseases has been discovered. UBL5 can stabilize the structure of...
2.
Guo W, Lu T, Song Y, Li A, Feng X, Han D, et al.
Cancer Med
. 2024 Jul;
13(14):e70039.
PMID: 39046176
Background: The presence of lymph node (LN) metastasis directly affects the treatment strategy for lung adenocarcinoma (LUAD). Next-generation sequencing (NGS) has been widely used in patients with advanced LUAD to...
3.
Cao Y, Huang B, Tang H, Dong D, Shen T, Chen X, et al.
BMJ Open Gastroenterol
. 2024 Mar;
11(1).
PMID: 38538088
Objective: This study aimed to develop and validate robust predictive models for patients with oesophageal cancer who achieved a pathological complete response (pCR) and those who did not (non-pCR) after...
4.
Li C, Ji A, Jian Z, Zheng Y, Feng X, Guo W, et al.
Transl Lung Cancer Res
. 2023 Sep;
12(8):1728-1737.
PMID: 37691871
Background: With the increasing number of small pulmonary nodules detected, effective localization of pulmonary nodules has become an issue. The goal of this study is to determine the safety and...
5.
Zhang Q, Feng X, Hu W, Li C, Sun D, Peng Z, et al.
Front Oncol
. 2023 Jun;
13:1169874.
PMID: 37388220
Background: Chronic obstructive pulmonary disease (COPD) and lung cancer are leading causes of morbidity and mortality worldwide. Studies have reported molecular alterations in patients with lung cancer and in patients...
6.
Li C, Zhang X, Feng X, Han D, Xiang J, Li H
JTCVS Tech
. 2023 Apr;
18:137-142.
PMID: 37096093
Objectives: Pulmonary segmentectomy should be the standard surgical procedure for patients in certain clinical scenarios. However, detecting the intersegmental planes both on the pleural surface and within the lung parenchyma...
7.
Yan Y, Feng X, Li C, Lerut T, Li H
Chin Med J (Engl)
. 2022 Dec;
135(18):2143-2156.
PMID: 36525602
Esophageal cancer (EC) has a high incidence and poor prognosis. The two major histological types, squamous cell carcinoma and adenocarcinoma, differ in their epidemiology and treatment options. Patients with locally...
8.
Jian Z, Han Y, Zhang W, Li C, Guo W, Feng X, et al.
Cell Biosci
. 2022 Aug;
12(1):135.
PMID: 35989326
Background: PI3K-Akt pathway activation and the expression of histone deacetylases (HDACs) are highly increased in esophageal cancer, suggesting that inhibition of such targets may be a viable therapeutic strategy. Herein,...
9.
Jian Z, Li C, Feng X, Yin Z, Han Y, Zhang Y, et al.
J Thorac Dis
. 2022 Jun;
14(5):1441-1449.
PMID: 35693598
Background: Combined anatomic subsegmentectomy performed by video-assisted thoracic surgery or robot-assisted thoracic surgery is an emerging minimally invasive surgical technique for patients with early-stage non-small cell lung cancer (NSCLC). However,...
10.
Mei Y, Feng X, Feng T, Yan M, Zhu Z, Li T, et al.
Front Pharmacol
. 2022 Mar;
13:845261.
PMID: 35250596
There is no global consensus on adjuvant chemotherapy (ACT) for pT2N0M0 gastric cancer. We conducted a retrospective study to reveal the role of ACT in such patients. Patients with pT2N0M0...